Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05574400 · ClinicalTrials.gov registry record · Phase 2
The Caffeine, Postoperative Delirium, and Change in Outcomes After Surgery (CAPACHINOS-2) Study
A Phase 2 study of Mild Cognitive Impairment and Postoperative Delirium, sponsored by University of Michigan.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT05574400 is a Phase 2 study of Mild Cognitive Impairment and Postoperative Delirium that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 250 participants, below the 1,269-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05574400, a Phase 2 study of Mild Cognitive Impairment and Postoperative Delirium, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to test the effects of caffeine on neurocognitive and clinical recovery after major surgery. Specifically, this trial tests the primary hypothesis that caffeine will reduce the incidence of postoperative delirium.
Conditions Studied
Interventions
- DRUG Dextrose Water
- DRUG Caffeine citrate
Study Locations (1)
Michigan
- Michigan Medicine - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2023-02-20 |
| Est. Completion | 2026-05-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05574400
The ClinicalTrials.gov registry entry for NCT05574400 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,269-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (80% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Dextrose Water is the first listed.
NCT05574400 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT05574400 about?
NCT05574400 is a clinical study titled "The Caffeine, Postoperative Delirium, and Change in Outcomes After Surgery (CAPACHINOS-2) Study". The objective of this study is to test the effects of caffeine on neurocognitive and clinical recovery after major surgery. Specifically, this trial tests the primary hypothesis that caffeine will reduce the incidence of postoperative delirium.
What is the current status of trial NCT05574400?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 250 participants. The study started on 2023-02-20. Estimated completion is 2026-05-31.
What conditions does trial NCT05574400 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment, Postoperative Delirium, Postoperative Cognitive Dysfunction.
What interventions are being tested in trial NCT05574400?
The interventions under investigation include: Dextrose Water (DRUG), Caffeine citrate (DRUG).
Who is sponsoring clinical trial NCT05574400?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05574400 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
RECRUITING · Phase 2
-
Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)
RECRUITING · Phase 2
-
Rapamycin - Effects on Alzheimer's and Cognitive Health
RECRUITING · Phase 2
-
The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults
RECRUITING · Phase 2
-
Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History
RECRUITING · Phase 2
-
Senicapoc in Alzheimer's Disease
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.